MiroliverELAP® for the Treatment of Acute Liver Failure: a Phase 1 Trial
The clinical trail will assess the safety of miroliverELAP for the treatment of acute
liver failure without underlying chronic liver disease. miroliverELAP is an external
liver assist combination product consisting of a single-use MIRO-001 bioengineered liver
graft a...
Age: 18 - 80 years
Gender: All
TReatment for ImmUne Mediated PathopHysiology
TReatment for ImmUne Mediated PathopHysiology (TRIUMPH) is a multi-center, three arm,
randomized, controlled trial of immunosuppressive therapy for children with acute liver
failure. The study will determine if suppressing inflammatory responses with either
corticost...
Age: 1 year - 18 years
Gender: All
TReatment for ImmUne Mediated PathopHysiology
TReatment for ImmUne Mediated PathopHysiology (TRIUMPH) is a multi-center, three arm, randomized, controlled trial of immunosuppressive therapy for children with acute liver failure. The study will determine if suppressing inflammatory responses with either corticostero...
Age: Birth - 18 years
Gender: All